First Time Loading...
S

Sipai Health Technology Co, Ltd
HKEX:314

Watchlist Manager
Sipai Health Technology Co, Ltd
HKEX:314
Watchlist
Price: 6.06 HKD 0.33% Market Closed
Updated: May 17, 2024
Section:
 

Wall Street
Price Targets

Price Targets Summary
Sipai Health Technology Co, Ltd

Wall Street analysts forecast Sipai Health Technology Co, Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Sipai Health Technology Co, Ltd is 8.73 HKD with a low forecast of 5.45 HKD and a high forecast of 12.3 HKD.

Lowest Forecast
Wall Street Target
5.45 HKD
10% Downside
Average Forecast
Wall Street Target
8.73 HKD
44% Upside
Highest Forecast
Wall Street Target
12.3 HKD
103% Upside
Lowest
Price Target
5.45 HKD
10% Downside
Average
Price Target
8.73 HKD
44% Upside
Highest
Price Target
12.3 HKD
103% Upside
Sipai Health Technology Co, Ltd Competitors:
Price Targets
605266
Yunnan Jianzhijia Health-Chain Co Ltd
62% Upside
FRAGUAB
Corporativo Fragua SAB de CV
3% Upside
3349
Cosmos Pharmaceutical Corp
22% Upside
002727
Yixintang Pharmaceutical Group Co Ltd
20% Upside
605266
Yunnan Jianzhijia Health-Chain Co Ltd
62% Upside
FRAGUAB
Corporativo Fragua SAB de CV
3% Upside
3349
Cosmos Pharmaceutical Corp
22% Upside
002727
Yixintang Pharmaceutical Group Co Ltd
20% Upside
F
FAR
Farmae SpA
60% Upside
RDC
Redcare Pharmacy NV
42% Upside
H
HL
Healthlead PCL
11% Upside
RADL3
Raia Drogasil SA
14% Upside

Revenue
Forecast

Revenue Estimate
Sipai Health Technology Co, Ltd

For the last 1 year the compound annual growth rate for Sipai Health Technology Co, Ltd's revenue is 19%. The projected CAGR for the next 4 years is 11%.

19%
Past Growth
11%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Sipai Health Technology Co, Ltd

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Sipai Health Technology Co, Ltd

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Sipai Health Technology Co, Ltd's stock price target?
Price Target
8.73 HKD

According to Wall Street analysts, the average 1-year price target for Sipai Health Technology Co, Ltd is 8.73 HKD with a low forecast of 5.45 HKD and a high forecast of 12.3 HKD.

What is Sipai Health Technology Co, Ltd's Revenue forecast?
Projected CAGR
11%

For the last 1 year the compound annual growth rate for Sipai Health Technology Co, Ltd's revenue is 19%. The projected CAGR for the next 4 years is 11%.

ALPHA SPREAD
Join more than 138,100+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.